Trial intelligence / Profile preview

Duloxetine for Chronic Postsurgical Pain After Total Hip Arthroplasty

jRCT1031210331Recruiting

Sponsor
Showa University School of Medicine
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of duloxetine in postoperative pain, Persistent postsurgical pain (PPSP) and hip osteoarthritis (2 arms), sponsored by Showa University School of Medicine. Primary endpoint: Change in NRS after total hip arthroplasty. Started Sep 2021; status: recruiting.

02

Drugs

duloxetine
03

Conditions

postoperative painPersistent postsurgical pain (PPSP)hip osteoarthritis

Beyond the preview

Go deeper on jRCT1031210331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031210331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call